---
name: medlog→OTel SEC/SRE/FIN panel response v2 (round 2 same day)
description: 2026-05-15 round-2 panel per-point on Deep×2 5-vector COI medlog→OTel; 0 CHALLENGE; 6 different panel-unique items than v1 (P1 6yr Loki TCO, P2 HIPAA SRA review pre-debate, P3 Loki query authz, P4 LogQL audit-job perf, P5 dual-write reconciliation, P6 defer-opportunity-cost); FIN correction — Deep $30–60K is decide-cost not execute-cost (full migrate $80–200K)
type: project
originSessionId: 5ef8af13-38ae-4283-b995-3d643a00cb7e
---
~42nd stacked-COI case / 9 domains. 2nd same-day SEC/SRE/FIN panel pass on Deep×2 medlog→OTel. Different panel-unique items vs v1 (project_arch_medlog_otel_panel_response.md), so worth its own entry.

**Convergence**: 0 CHALLENGE bidirectional, ~30/35 AGREE on Deep points, ~10 sharpened SYNTHESIZE.

**6 panel-unique findings (different from v1 set)**:
- **P1 (FIN HIGH)**: 6yr Loki retention TCO unmodeled vs ES at HIPAA healthcare volume; cold-tier query latency may break 7h audit window
- **P2 (SEC HIGH)**: Review HIPAA SRA / risk register *before* this debate — D1 75% audit failure rate may already be documented control deficiency
- **P3 (SEC MED)**: Application-layer tenant isolation requires enforced Loki query authz + Grafana org boundaries
- **P4 (SRE MED)**: Audit-job rewrite (LogQL vs ES) architecturally distinct — must benchmark separately
- **P5 (SEC MED)**: Dual-write creates split audit trail; needs reconciliation spec
- **P6 (FIN LOW)**: "Defer + re-litigate in 18mo" opportunity cost ≈ migration cost

**FIN cost correction (largest panel-vs-Deep delta)**:
- Deep $30–60K = *commit-to-decide* (Phases 0–2)
- Full execution if migrate chosen: **$80–200K + 6–9 months**
- Avoid mis-selling decide-gate as total bill to CFO

**Verdict stable**: stabilise → document-14 → external HIPAA review → 30d shadow spike → recuse-of-3 gate → conditional migrate.

**Cross-round comparison v1 vs v2 (same Deep input, same date)**:
- Both rounds: 0 CHALLENGE, recuse-of-3 + F5/E2 unanimous load-bearing
- v1 panel-unique focused on: Grafana access controls, WORM/immutability, OTel ops expertise, loss-EV framing, TCO, Kafka ACLs
- v2 panel-unique focused on: TCO (overlap), HIPAA SRA review, query authz, LogQL perf, dual-write reconciliation, defer opportunity cost
- Only TCO overlaps — suggests panel has not saturated panel-unique discovery yet, even though Deep COI seat has saturated
- Pattern: full-context Deep seats saturate around round 5–10 per domain; role-lens panels keep finding new items because they bring different priors
